Overview
Hongliang Li practices in Wuhan, China. Li is highly rated in 7 conditions, according to our data. Their top areas of expertise are Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Pneumonia, Atherosclerosis, and Liver Transplant.
Their clinical research consists of co-authoring 288 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Non-Alcoholic Fatty Liver Disease
- Nonalcoholic Steatohepatitis (NASH)
- Advanced
- AtherosclerosisLi isAdvanced. Learn about Atherosclerosis.
- COVID-19Li isAdvanced. Learn about COVID-19.
- PneumoniaLi isAdvanced. Learn about Pneumonia.
- Severe Acute Respiratory Syndrome (SARS)
- VasoconstrictionLi isAdvanced. Learn about Vasoconstriction.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- AsthmaLi isExperienced. Learn about Asthma.
- Atrial FibrillationLi isExperienced. Learn about Atrial Fibrillation.
- Breast CancerLi isExperienced. Learn about Breast Cancer.
- CardiomyopathyLi isExperienced. Learn about Cardiomyopathy.
- Carotid Artery DiseaseLi isExperienced. Learn about Carotid Artery Disease.